Ephla Bio is a startup based in the United Kingdom, most recent round Seed, 1 tracked investor.
Ephla Bio is a company headquartered in the United Kingdom. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Ephla Bio develops targeted B-cell therapeutics designed to address immune-related conditions using machine learning, offering clinician and researcher-led development for individuals with autoimmune disorders and blood cancers.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.